VAR - Varian Medical Systems, Inc.
| Previous Close | 132.80 |
| Open | 132.97 |
| Bid | 132.08 x 900 |
| Ask | 132.06 x 1100 |
| Day's Range | 131.93 - 133.56 |
| 52 Week Range | 101.42 - 142.50 |
| Volume | 605,427 |
| Avg. Volume | 530,244 |
| Market Cap | 12.02B |
| Beta (3Y Monthly) | 0.94 |
| PE Ratio (TTM) | 32.11 |
| EPS (TTM) | 4.12 |
| Earnings Date | Jul 24, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | 1998-12-02 |
| 1y Target Est | 150.00 |
- Simply Wall St.•3 days ago
Varian Medical Systems (NYSE:VAR) Shareholders Have Enjoyed A 61% Share Price Gain
Generally speaking the aim of active stock picking is to find companies that provide returns that are superior to the...
- Zacks•4 days ago
What's in Store for Varian Medical (VAR) in Q3 Earnings?
Probable revenue growth in APAC and EMEA regions and higher Oncology revenues are likely to aid Varian Medical (VAR) in Q3 earnings. However, contraction in margins might be a dampener.
- Zacks•5 days ago
Will USTR's 25% Tariff Exemption Spell Relief for MedTech?
In the wake of the U.S. tariff and Chinese retaliation, the MedTech industry players (with production houses in China) are facing huge bottom line pressure.
- Zacks•6 days ago
Varian Medical Systems (VAR) Earnings Expected to Grow: Should You Buy?
Varian (VAR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks•6 days ago
US-India Trade Tensions Rise: 3 Stocks in the Line of Fire
As India moves toward self-sufficiency, U.S. MedTech bigwigs fret over possible losses.
- GuruFocus.com•8 days ago
Varian Medical Systems Inc (VAR) SVP, Finance & CFO Gary E Jr Bischoping Sold $7. ...
SVP, Finance & CFO of Varian Medical Systems Inc (30-Year Financial, Insider Trades) Gary E Jr Bischoping (insider trades) sold 56,232 shares of VAR on 07/11/2019 at an average price of $132.56 a share. Continue reading...
- PR Newswire•12 days ago
Varian to Showcase Cancer Care Systems and Software at AAPM 2019
PALO ALTO, Calif. , July 11, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced it will be showcasing systems and software from its cancer care portfolio, including the IDENTIFY ™ Guidance System, ...
- Zacks•13 days ago
Stock Market News For Jul 10, 2019
Markets closed mostly higher on Tuesday as investors awaited Powell's testimony.
- Zacks•13 days ago
Varian (VAR) Installs ProBeam Compact in Thailand's Hospital
Varian (VAR) gains from a slew of recent developments in its Proton Therapy platform.
- Reuters•14 days ago
U.S. exempts some medical, electronic devices from China tariffs
The Trump administration will exempt 110 Chinese products, from medical equipment to key capacitors, from hefty tariffs, it said on Tuesday, offering relief to some U.S. firms which have said the taxes harm their bottom lines. The relatively narrow exemption list will provide relief from 25% tariffs the United States slapped on $34 billion of Chinese imports on July 6, 2018, one of the first salvos in a bilateral trade battle that has roiled global supply chains and cost billions. U.S. and Chinese negotiators are scheduled to resume talks this week after a two-month hiatus, a year since their tit-for-tat tariff battle began.
- Zacks•14 days ago
Varian (VAR) to Boost Cancer Treatment With New Partnership
Varian (VAR) expects to enhance cancer care with the new collaboration with IAEA, which is likely to drive Varian's core Oncology business.
- PR Newswire•14 days ago
Cyclotron for Varian ProBeam Compact Proton Therapy System Installed at King Chulalongkorn Memorial Hospital, Bangkok, Thailand
Her Royal Highness Princess Maha Chakri Sirindhorn Presided Over Rigging Ceremony PALO ALTO, Calif. , July 9, 2019 /PRNewswire/ -- Varian (NYSE: VAR) celebrated the installation of the cyclotron for its ...
- PR Newswire•15 days ago
Varian Provides TrueBeam System for IAEA Dosimetry Laboratory in Austria
PALO ALTO, Calif. , July 8, 2019 /PRNewswire/ -- Varian (NYSE: VAR) is working in partnership with the International Atomic Energy Agency (IAEA) to improve cancer treatment by helping hospitals around ...
- Zacks•20 days ago
Varian to Acquire Boston Scientific's Embolic Bead Products
Varian (VAR) expects the buyout to prove accretive to its fiscal 2020 reported and adjusted earnings per share.
- Benzinga•21 days ago
Varian Will Acquire Embolic Bead Asset From Boston Scientific
Varian Medical Systems (NYSE: VAR ) will acquire Boston Scientific’s (NYSE: BSX ) portfolio of drug-loadable microsphere and bland embolic bead products. Terms of the transaction were not disclosed. Boston ...
- PR Newswire•21 days ago
Varian to Expand Interventional Oncology Portfolio with Purchase of Embolic Bead Asset
PALO ALTO, Calif., July 2, 2019 /PRNewswire/ -- Varian (VAR) today announced it has signed an asset purchase agreement to acquire the Boston Scientific portfolio of drug-loadable microsphere and bland embolic bead products for treating arteriovenous malformations and hypervascular tumors. When completed, this acquisition, in combination with the recent acquisitions of Endocare and Alicon, will expand Varian's portfolio of multidisciplinary integrated cancer care solutions. Varian's planned acquisition of the Boston Scientific portfolio of drug-loadable microsphere (Oncozene/Embozene Tandem) and bland embolic (Embozene) bead products will enable Varian to extend its new interventional oncology platform, and the Company will benefit from the products' regulatory clearances in more than 35 countries worldwide.
- Simply Wall St.•22 days ago
Estimating The Fair Value Of Varian Medical Systems, Inc. (NYSE:VAR)
Does the July share price for Varian Medical Systems, Inc. (NYSE:VAR) reflect what it's really worth? Today, we will...
- Zacks•22 days ago
Here's Why You Should Hold Varian Medical (VAR) Stock Now
Varian (VAR) expects the Cancer Treatment Services International buyout to prove accretive to earnings per share during fiscal 2021.
- Zacks•26 days ago
Varian (VAR) & Tennessee Oncology to Implement Use of Noona
Varian's (VAR) core Oncology unit gets a boost from the latest collaboration with Tennessee Oncology.
- PR Newswire•27 days ago
Varian Announces Third Quarter Fiscal Year 2019 Earnings Release Date
PALO ALTO, Calif. , June 26, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced its third quarter fiscal year 2019 earnings release date. The Company will report results for the third quarter of fiscal ...
- PR Newswire•27 days ago
Varian to Provide Mobile Technology to Cancer Patients Across Tennessee
Collaboration with Tennessee Oncology Aims to Improve Access to Care Across Rural Patient Populations PALO ALTO, Calif. , June 26, 2019 /PRNewswire/ -- Providing cancer patients an opportunity for increased ...
- Zacks•last month
Near-Term Outlook for Medical Instruments Industry Bleak
Near-Term Outlook for Medical Instruments Industry Bleak
- PR Newswire•last month
Varian Completes Acquisition of Cancer Treatment Services International
PALO ALTO, Calif. , June 17, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced it has successfully completed its acquisition of Cancer Treatment Services International (CTSI). There were no changes ...
- PR Newswire•last month
Varian to Deliver Six Technical Presentations at ICCR
PALO ALTO, Calif. , June 13, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced it will be delivering presentations focused on artificial intelligence (AI), federated data sources and clinical decision ...
